trial · primary record
18F-PF974
Alzheimer s Disease
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 90 |
| Primary completion | 2030-04-11 |
| Primary endpoint | To determine whether PDE4B radioligand binding is increased in medial temporal lobe of participants with AD or MCI (both A <= positive) compared to age-and sex matched HVs (who are A <= negative. |
| Registry ID | NCT07169630 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:32.663Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07169630
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.